Shelly C. Shand, MD

Medical Oncology and Hematology Specialist

Shelly Christiansen Shand, MD graduated from the University of Georgia and earned her Doctorate of Medicine from Mercer University School of Medicine in her hometown of Savannah. She completed her internship and residency in Internal Medicine at the University of Utah in Salt Lake City, where she was selected as a member of the Alpha Omega Alpha Honor Society for her gifted teaching, professionalism, and scholarship. She completed her fellowship in hematology and medical oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Hospital in Washington, DC.

Dr. Shand has led clinical research at the forefront of oncology including clinical trial and protocol development in breast cancer, immune therapy, and melanoma. She presented this research at national meetings, including the annual American Society of Clinical Oncology (ASCO) conference, and authored publications and abstracts on these and other topics in hematology and oncology.

Above her interest in clinical research, Dr. Shand’s primary concern is for her patients. By combining exceptional patient care with the most cutting-edge treatments, she will tailor each patient’s plan of care to meet his or her individual needs and concerns. Dr. Shelly Shand is a board-certified physician and a member of the American College of Physicians, American Society of Clinical Oncology, American Society of Hematology, and Alpha Omega Alpha Honor Society. She joined Charleston Oncology in 2018. Dr. Shand is married and enjoys spending time with family, friends, and her two cats. She also enjoys traveling, yoga, and savoring the culinary offerings of Charleston.

Choose your preferred location

West Ashley

North Charleston



Mt. Pleasant


Send UsA Message

    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...

    read more
    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”

    read more
    Call Now Button